180 Life Sciences has announced a $425 million private placement to acquire Ethereum as its primary treasury asset, with the funding round expected to close by August 1. The company will rebrand as ETHZilla Corporation following the closure. The round attracted over 60 institutional and crypto-native investors, including Electric Capital and Polychain. Electric Capital will manage ETHZilla's Ethereum holdings using an innovative on-chain yield strategy. Additionally, ETHZilla is partnering with Etherealize to establish a DeFi Council to guide its Ethereum treasury deployment and yield strategies. This move underscores a shift in public company treasury management towards Ethereum, signaling increased institutional confidence in its potential as a yield-generating asset.